The effects of phosphonoacetic acid on cell growth, expression of Epstein-Barr virus antigens, and virus production in human and marmoset lymphoblastoid cell lines have been studied. The drug had no significant effect at concentrations up to 100 jg/ml on cell growth or total cell DNA synthesis. Hi' er doses induced not only a drastic decrease in DNA synthesis and cell growth, but also a dramatic cell enlargement. Immunofluorescence studies showed that >30 jsg/ml of phosphonoacetic acid inhibited viral capsid antigen synthesis without affecting the expression of the nuclear antigen or the spontaneous and 5-iodo-2'-deoxyuridineinduced early antigens. Production of transforming EpsteinBarr virus was also blocked. Inhibition of viral capsid antigen expression and of virus production at low doses was reversible. The (human fibroblast) cells (3). PAA inhibits herpes simplex virus replication by interfering with the DNA polymerase activity (4). It has also been found to inhibit the replication of several other herpes viruses, including cytomegalovirus (5), Marek's disease virus (6), and equine abortus virus (7), and a non-herpes virus, vaccinia virus (8). In this paper we present data which show that PAA inhibits the synthesis of Epstein-Barr (EBV) viral capsid antigens (VCA) and of virus itself at concentrations which have no detectable effect on the synthesis of nuclear antigen (EBNA) and early antigens (EA), or on cellular DNA synthesis and cell proliferation. PAA also has no detectable effect on 5-iodo-2'-deoxyuridine-(IdUrd) or superinfection-induced EA synthesis in the nonproducer Raji cell line.
ABSTRACT
The effects of phosphonoacetic acid on cell growth, expression of Epstein-Barr virus antigens, and virus production in human and marmoset lymphoblastoid cell lines have been studied. The drug had no significant effect at concentrations up to 100 jg/ml on cell growth or total cell DNA synthesis. Hi' er doses induced not only a drastic decrease in DNA synthesis and cell growth, but also a dramatic cell enlargement. Immunofluorescence studies showed that >30 jsg/ml of phosphonoacetic acid inhibited viral capsid antigen synthesis without affecting the expression of the nuclear antigen or the spontaneous and 5-iodo-2'-deoxyuridineinduced early antigens. Production of transforming EpsteinBarr virus was also blocked. Inhibition of viral capsid antigen expression and of virus production at low doses was reversible. The transforming virus produced after the removal of the drug from the B95-8 marmoset cell line transformed peripheral blood lymphocytes as effectively as virus prepared from untreated cells. It is known that the expression of viral capsid antigen but not early antigen requires viral DNA synthesis. Therefore, these results suggest that phosphonoacetic acid interferes specifically with viral DNA synthesis at concentrations that do not affect cellular DNA synthesis. The recent discovery of the anti-viral activity of phosphonoacetic acid (PAA) in a random screening test of compounds has aroused intense interest in this chemical. The antiviral activity was demonstrated in herpes simplex virus types 1 and 2 infection of rabbits (1, 2) and in the infection of cultured (human fibroblast) cells (3) . PAA inhibits herpes simplex virus replication by interfering with the DNA polymerase activity (4) . It has also been found to inhibit the replication of several other herpes viruses, including cytomegalovirus (5), Marek's disease virus (6) , and equine abortus virus (7) , and a non-herpes virus, vaccinia virus (8) . In this paper we present data which show that PAA inhibits the synthesis of Epstein-Barr (EBV) viral capsid antigens (VCA) and of virus itself at concentrations which have no detectable effect on the synthesis of nuclear antigen (EBNA) and early antigens (EA), or on cellular DNA synthesis and cell proliferation. PAA also has no detectable effect on 5-iodo-2'-deoxyuridine-(IdUrd) or superinfection-induced EA synthesis in the nonproducer Raji cell line.
MATERIALS AND METHODS
Cell Cultures. Lymphoblastoid cell lines B95-8, P3HR-1, nd Raji used in this investigation were obtained from Dr. 7eorge Klein and from Pfizer, Inc. The B95-8 cell line is an EBV-transformed marmoset lymphocyte line which proluces a lymphocyte-transforming virus (9) . P3HR-1 and laji are Burkitt's lymphoma-derived lines which produce iontransforming cytopathic EBV (10) Cells were stained for EBNA by the anticomplement immunofluorescence method (17) using the three-step procedure (18) . In preparing cells for staining, it is essential that the smears be dried almost instantly. To facilitate this, Long-Term Effect of PAA on Viral Activities. Two duplicate sets of B95-8 cultures were prepared in either 30 ,ug/ml or 100 jg/ml of PAA, together with controls. Cell smears were prepared from each culture every 24-48 hr and stained for EA and VCA. To see whether inhibited cells can regain their ability to synthesize VCA, we split the PAAtreated cultures into two portions, one of which we continued to treat with PAA while the other was washed free of PAA and subsequently maintained in PAA-free media. Smears were prepared and stained for VCA and EA as before.
Lymphocyte Transformation. The effect of PAA on the production of transforming EBV in B95-8 cells was studied by the lymphocyte transformation assay (19) with some modification. Aliquots of the cultures used for studying the long-term effect of PAA on EBV (see above) were utilized for virus preparation. Six days after the initiation of PAA treatment, cells treated with 100 ,gg/ml of the drug together with controls were washed three times with regular growth medium. The experimental cultures were split into two portions, one of which was fed with medium containing 100 ,ug/ml of PAA while the other was fed with regular growth medium. After 7 days at 370 without feeding virus was prepared by pelleting the suspension at 1000 rpm (Sorvall GLC-2) for 5 min, clarifying the resulting supernatant at 2000 rpm for 10 min, dividing it into aliquots, and freezing it at -70°until needed. Purified bone-marrow-derived (B) lymphocytes from peripheral blood were transformed with a 1:20 dilution of the virus preparation at 370 in microtiter plates (Falcon Plastics). PAA was added to the virus prepared from PAA-free cultures in order to compensate for the effect of residual PAA present in preparations from PAAtreated cultures. After 7 days, EBV-induced blast transformation was measured by pulse-labeling the cultures with 0.4 ,uCi/ml of [3H]dThd (New England Nuclear, specific activity: 2 Ci/mmol) for 16 hr, and counting radioactivity in the acid-insoluble materials.
RESULTS
Effect of PAA on Cell Growth and DNA Synthesis. Growth of the marmoset B95-8 cells in various PAA concentrations over a 154 hr period was measured (Fig. 1) . Concentrations less than 100 tig/ml had no significant effect on cell growth, while concentrations greater than 500 ,ug/ml completely inhibited cell growth. These effects on cell growth were paralleled by effects on total cell DNA synthesis.
Treatment of B95-8 cells with [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] .ug/ml of PAA had no significant effect on DNA synthesis as measured by
[3H]dThd incorporation into acid-insoluble materials. About 240 ,ug/ml caused a 50% reduction and 500 ,tg/ml caused about a 75% reduction in DNA synthesis (Fig. 2) with any of the cellular processes which usually follow chromosomal DNA replication. Differential Effect of PAA on EBV Antigen Expression. In P3HR-1 cells (a human lymphoblastoid line which is the commonly used producer of infectious EBV), PAA inhibited expression of VCA but not EA (Fig. 3) . VCA synthesis was markedly inhibited by 30 jig/ml of PAA, whereas even 100 ,ug/ml had little effect on cell growth. EA synthesis was not affected at even 500 ,ug/ml. Similarly, VCA synthesis in B95-8 cells (a marmoset lymphoblastoid line which produces a transforming strain of EBV) was markedly sensitive to PAA, while EA synthesis was unaffected (Figs. 4 and 5) .
The inhibitory effect of PAA on VCA synthesis was first observed at about 4 days (Fig. 5) . One possible explanation for the lag is that VCA seen between day 0 and day 3 is not newly synthesized antigen but rather is that already synthesized or in the process of being synthesized when drug treatment was initiated. This VCA would mask the effect of PAA on new VCA until it is lost after cell lysis. A lag in drug penetration could also account for part of this result.
The effect of PAA on VCA expression was independent of the duration of treatment. VCA synthesis in cells that were continuously treated with PAA for 3 months was still inhibited as at day 4. The level of EA remained consistently unaffected. When PAA was removed from the growth medium, VCA synthesis was restored whether the cells had been treated with 30 or with 100 jig/ml and even after [7] [8] [9] [10] weeks of treatment (Table 1) . Upon removal of PAA several days were required before the VCA level equaled that of untreated cells. The time for reappearance of VCA was the same whether the cells had been treated for 1 week or for 7 weeks with PAA. PAA treatment had no detectable effect on EBNA expression in either producer or non-producer lines (Tables 1 and 2 ) regardless of the time of exposure or the concentration used. About 90% of both treated and control cells synthesized EBNA. This finding agrees well with the (20) . PAA had no effect on either of these processes (Table 2 ). This observation is in contrast to the finding of Klein and Dombos that a DNA inhibitor such as cytosine arabinonucleoside (Ara-C) completely inhibited IdUrd induction. (2) . However, concentrations which completely inhibited cell growth did not kill cells but merely arrested them at interphase. Cells so arrested became larger than untreated ones, but this effect was reversible. Possibly, PAA at high concentrations might inhibit some specific functions such as the initiation of DNA synthesis by competing with factors which normally occur in the cell.
PAA specifically inhibits some but not all EBV functions. None of the concentrations tested (up to 500 ,ug/ml) had any detectable effect on EBNA or EA, whereas 30 ,gg/ml inhibited VCA synthesis. Furthermore, PAA did not inhibit the expression of EA after induction of the endogenous virus by IdUrd or superinfection with P3HR-1. These observations agree with those of other investigators that DNA synthesis is not required for the expression of early EBV functions such as EA and membrane antigen (MA) (21) . The lack of effect of PAA on induction and superinfection also suggests that the mechanisms involved in these two phenomena do not require a PAA-sensitive DNA synthesis. In contrast, cytosine arabinonucleoside, which completely inhibits induction but not superinfection, presumably does so by preventing both cellular and viral DNA synthesis (20) , whereas PAA fails to do so because it has no effect on cellular DNA synthesis. In order to explain their results, Klein and Dombos (20) non-VGA-synthesizing cells), or a requirement for independently replicating viral DNA in the expression of this gene. A similar phenomenon has been observed for expression of some of the late genes in bacteriophage T4 (23) .
The selective inhibition of EBV replication by PAA may facilitate the selection of mutant EBV strains similar to the recently reported isolation of PAA-resistant strains of herpes simplex virus (24, 25) . Furthermore, the reversibility of PAA inhibition might facilitate the study of EBV-cell regulatory mechanisms in somatic cell hybrids. That is, it might be possible by controlling virus production with PAA to isolate some types of hybrids which would otherwise fail to survive.
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